Stroke after bone marrow transplantation frequency, aetiology and outcome

Brain

Volumn 124, Issue 5, 2001, Pages 1043-1051

  Coplin, William M ^a,b,d   Cochran, Mary S ^b   Levine, Steven R ^b   Crawford, Steven W ^a,c,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone marrow transplant; Cerebrovascular disease; Epidemiology; Infection; Stroke

Indexed keywords

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN HEMORRHAGE; BRAIN INFECTION; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; DEMOGRAPHY; FEMALE; HUMAN; INCIDENCE; MALE; MYCOSIS; PRIORITY JOURNAL; RADIODIAGNOSIS; REGISTER; REGRESSION ANALYSIS; THROMBOCYTOPENIA;

EID: 0034998472     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/124.5.1043     Document Type: Article

References (49)

1. Abboud MR, Jackson SM, Barredo J, Holden KR, Cure J, Laver J. Neurologic complications following bone marrow transplantation for sickle cell disease. Bone Marrow Transplant 1996; 17: 405-7.
2. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. Stroke 1993; 24: 35-41.
3. Ashdown BC, Tien RD, Felsberg GJ. Aspergillosis of the brain and paranasal sinuses in immunocompromised patients: CT and MR imaging findings. AJR Am J Roentgenol 1994; 162: 155-9.
4. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-6.
5. Beal MF, O'Carroll CP, Kleinman GM, Grossman RI. Aspergillosis of the nervous system. Neurology 1982; 32: 473-9.
6. Benesch C, Witter DM Jr, Wilder AL, Duncan PW, Samsa GP, Matchar DB. Inaccuracy of the International Classification of Diseases (ICD-9-CM) in identifying the diagnosis of ischemic cerebrovascular disease. Neurology 1997; 49: 660-4.
7. Bhave AA, Thirunavukkarasu K, Gottlieb DJ, Bradstock K. Disseminated nocardiosis in a bone marrow transplant recipient with chronic GVHD. Bone Marrow Transplant 1999; 23: 519-21.
8. Choucino C, Goodman SA, Greer JP, Stein RS, Wolff SN, Dummer JS. Nocardial infections in bone marrow transplant recipients. [Review]. Clin Infect Dis 1996; 23: 1012-9.
9. Coley SC, Jager HR, Szydlo RM, Goldman JM. CT and MRI manifestations of central nervous system infection following allogeneic bone marrow transplantation. Clin Radiol 1999; 54: 390-7.
10. Davis DG, Patchell RA. Neurologic complications of bone marrow transplantation. [Review]. Neurol Clin 1988; 6: 377-87.
11. DeLone DR, Goldstein RA, Petermann G, Salamat MS, Miles JM, Knechtle SJ, et al. Disseminated aspergillosis involving the brain: distribution and imaging characteristics. AJNR Am J Neuroradiol 1999; 20: 1597-604.
12. Denning DW, Evans EG, Kibbler CC, Richardson MD, Roberts MM, Rogers TR, et al. Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. British Society for Medical Mycology. Eur J Clin Microbiol Infect Dis 1997; 16: 424-36.
13. Diener HC, Ehninger G, Schmidt H, Stab U, Majer K, Marquardt B. Neurologic complications after bone marrow transplantation. [Review]. Nervenarzt 1991; 62: 221-5.
14. Ferster A, Christophe C, Dan B, Devalck C, Sariban E. Neurologic complications after bone marrow transplantation for sickle cell anemia [letter]. Blood 1995; 86: 408-9.
15. Freedman AS, Nielsen GP. Case records of the Massachusetts General Hospital: Case 11-1999: a 60-year-old woman with epidural and paraspinal masses. N Engl J Med 1999; 340: 1188-96.
16. Furlong TG, Gallucci BB. Pattern of occurrence and clinical presentation of neurological complications in bone marrow transplant patients. Cancer Nurs 1994; 17: 27-36.
17. Gallardo D, Ferra C, Berlanga JJ, Banda ED, Ponce C, Salar A, et al. Neurologic complications after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 18: 1135-9.
18. Goldstein LB. Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke 1998; 29: 1602-4.
19. Gordon BG, Saving KL, McCallister JA, Warkentin PI, McConnell JR, Roberts WM, et al. Cerebral infarction associated with protein C deficiency following allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 8: 323-5.
20. Gordon BG, Haire WD, Patton DF, Manno PJ, Reed EC. Thrombotic complications of BMT: association with protein C deficiency. Bone Marrow Transplant 1993; 11: 61-5.
21. Graus F, Saiz A, Sierra J, Arbaiza D, Rovira M, Carreras E, et al. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: a comparative study. Neurology 1996; 46: 1004-9.
22. Hagensee ME, Bauwens JE, Kjos B, Bowden RA. Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. Clin Infect Dis 1994; 19: 402-8.
23. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ 1976; 54: 541-53.
24. Hooper DC, Pruitt AA, Rubin RH. Central nervous system infection in the chronically immunosuppressed. [Review]. Medicine (Baltimore) 1982; 61: 166-88.
25. Irle C, Deeg HJ, Buckner CD, Kennedy M, Clift R, Storb R, et al. Marrow transplantation for leukemia following fractionated total body irradiation: a comparative trial of methotrexate and cyclosporine. Leuk Res 1985; 9: 1255-61.
26. Jantunen E, Piilonen A, Volin L, Parkkali T, Koukila-Kahkola P, Ruutu T, et al. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000; 25: 867-71.
27. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1: 480-4.
28. Kay HE, Watson JG, Jameson B, Morgenstern GR, Powles RL. Infections after bone marrow transplantation using cyclosporine. Transplantation 1983; 36: 491-5.
29. Khoury H, Adkins D, Miller G, Goodnough L, Brown R, DiPersio J. Resolution of invasive central nervous system aspergillosis in a transplant recipient. Bone Marrow Transplant 1997; 20: 179-80.
30. Lind MJ, McWilliam L, Jip J, Scarffe JH, Morgenstern GR, Chang J. Cyclosporin associated demyelination following allogeneic bone marrow transplantation. Hematol Oncol 1989; 7: 49-52.
31. Maschke M, Dietrich U, Prumbaum M, Kastrup O, Turowski B, Schaefer UW, et al. Opportunistic CNS infection after bone marrow transplantation. Bone Marrow Transplant 1999; 23: 1167-76.
32. Meyers JD. Fungal infections in bone marrow transplant patients. Semin Oncol 1990; 17 (3 Suppl 6): 10-3.
33. Mohrmann RL, Mah V, Vinters HV. Neuropathologic findings after bone marrow transplantation: an autopsy study. Hum Pathol 1990; 21: 630-9.
34. Moore TB, Chow VJ, Ferry D, Feig SA. Intracardiac right-to-left shunting and the risk of stroke during bone marrow infusion. Bone Marrow Transplant 1997; 19: 855-6.
35. Nakamura N, Akiyama H, Mishima K, Onozawa Y. Subdural hematoma during allogeneic bone marrow transplantation for chronic myelogenous leukemia [letter]. Acta Haematol 1992; 88: 163-4.
36. Patchell RA. Neurological complications of organ transplantation. [Review]. Ann Neurol 1994; 36: 688-703.
37. Patchell RA, White CL 3d, Clark AW, Beschorner WE, Santos GW. Neurologic complications of bone marrow transplantation. Neurology 1985; 35: 300-6.
38. Price TR, Psaty B, O'Leary D, Burke G, Gardin J. Assessment of cerebrovascular disease in the Cardiovascular Health Study. Ann Epidemiol 1993; 3: 504-7.
39. Reece DE, Frei-Lahr DA, Shepherd JD, Dorovini-Zis K, Gascoyne RD, Graeb DA, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991; 8: 393-401.
40. Schwartz S, Thiel E. Clinical presentation of invasive aspergillosis. [Review]. Mycoses 1997; 40 Suppl 2: 21-4.
41. Snider S, Bashir R, Bierman P. Neurologic complications after highdose chemotherapy and autologous bone marrow transplantation for Hodgkin's disease. Neurology 1994; 44: 681-4.
42. Toole JF, Chambless LE, Heiss G, Tyroler HA, Paton CC. Prevalence of stroke and transient ischemic attacks in the Atherosclerosis Risk in Communities (ARIC) study. Ann Epidemiol 1993; 3: 500-3.
43. van Burik JA, Hackman RC, Nadeem SQ, Hiemenz JW, White MH, Flowers ME, et al. Nocardiosis after bone marrow transplantation: a retrospective study. Clin Infect Dis 1997; 24: 1154-60.
44. von Kummer R. Early neuroradiological predictors of mortality after ischemic stroke [letter]. Stroke 1995; 26: 1125.
45. von Kummer R, Nolte PN, Schnittger H, Thron A, Ringelstein EB. Detectability of cerebral hemisphere ischaemic infarcts by CT within 6 h of stroke. Neuroradiology 1996; 38: 31-3.
46. Walsh TJ, Hier DB, Caplan LR. Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Ann Neurol 1985; 18: 574-82.
47. Walters MC, Sullivan KM, Bernaudin F, Souillet G, Vannier JP, Johnson FL, et al. Neurologic complications after allogeneic marrow transplantation for sickle cell anemia. Blood 1995; 85: 879-84.
48. Wiznitzer M, Packer RJ, August CS, Burkey ED. Neurological complications of bone marrow transplantation in childhood. Ann Neurol 1984; 16: 569-76.
49. Yuh WT, Nguyen HD, Gao F, Tali ET, Fisher DJ, Mayr NA, et al. Brain parenchymal infection in bone marrow transplantation patients: CT and MR findings. AJR Am J Roentgenol 1994; 162: 425-30.